Form 4 for EFX Equifax
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001225208-23-001885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-10 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +9,799 | 77.8K | +14% | $0 |
| DM | 2023-02-14 | 2023-02-10 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +34.9K | 18.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | A | A | 9,799 | $0.00 | 77,831 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2023-02-10 | A | A | 16,580 | $0.00 | 16,580 | D | $226.78 · 2026-02-10 to 2031-02-10 | 16,580 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on February 10, 2026. |
| 3 | Derivative | Stock Option/Right to Buy | 2023-02-10 | A | A | 18,346 | $0.00 | 18,346 | D | $247.39 · 2026-02-10 to 2031-02-10 | 18,346 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on February 10, 2026. |